TIS 0.00% 0.0¢ tissue therapies limited

relax regarding ce and website, page-19

  1. 492 Posts.
    Thanks Jsmama

    This is reassuring on two fronts. Firstly that VitroGrow production is not occurring at the maximum production rate so that capacity can increase prior to a need to invest in new productive capacity/techniques. Secondly that in the future there may not be as large a gap between incurring production costs and receiving sales revenue. The next 4C will be interesting.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.